Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Filings indexed 1,226 across all filing types
Latest filing 2017-05-23 Director's Dealing
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
FORM 4 -
Director's Dealing
2017-05-23 English
NONE
Major Shareholding Notification
2017-05-09 English
10-Q
Interim / Quarterly Report Q1 2017
2017-05-05 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 5, 2017. It reports "Other Events" related to a press release about positive results from a clinical study (Salford Lung Study) involving a pharmaceutical product. The document includes a press release as an exhibit and does not contain financial statements or detailed financial data. The length is 3844 characters, which is relatively short and consistent with an announcement rather than a full report. The content is primarily an announcement of a significant event (clinical trial results) rather than financial results, management changes, or regulatory certifications. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2017-05-05 English
8-K
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content focuses on legal proceedings related to a Delaware Court of Chancery case involving the company, including briefs filed in support of motions. There are no financial statements, earnings data, or management discussion of financial results. The document includes exhibits related to legal briefs and is primarily a regulatory disclosure of legal matters. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. Given the focus on legal proceedings and the nature of the filing, the most appropriate classification is Legal Proceedings Report (LTR). The document length and detail support this classification with high confidence.
2017-05-02 English
8-K/A
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K/A filed with the SEC, specifically an amendment to a previous 8-K filing. It provides detailed final voting results from the company's Annual Meeting of Stockholders held on April 20, 2017. The content focuses on the submission of matters to a vote of security holders, including election of directors, advisory votes on executive compensation, and ratification of the independent auditor. There is no financial data or report content, but rather the official disclosure of shareholder voting outcomes. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is sufficient and contains detailed vote counts, confirming it is not a mere announcement of a report but the actual voting results disclosure.
2017-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.